Compare Ginkgo Bioworks Holdings Inc (DNA) vs VanEck Vietnam ETF (VNM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs VanEck Vietnam ETF — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.34 (market cap $505.73M), while VanEck Vietnam ETF trades at $17.84. The key difference: VanEck Vietnam ETF is trading nearer its 52-week high, Ginkgo Bioworks Holdings Inc nearer its low. Which is the better fit depends on your goals.
| DNA | VNM | |
|---|---|---|
Market Cap | $505.73M | — |
Sector | Health | Sector/Thematic |
52-Week High | $16.14 | $19.80 |
52-Week Low | $5.48 | $16.34 |
Enterprise Value | $607.68M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ginkgo Bioworks (DNA) trades at $7.42, down 3.01% with bearish technical signals. The company reported Q2 2026 revenue of $20M, down 48% year-over-year, while maintaining a high gross margin of 68.04% but significant net losses. Analyst sentiment is mixed with 45% buy ratings amid ongoing business model transition to autonomous laboratory systems and contract research services.
The outlook remains challenging with persistent revenue declines and negative cash flow, though recent earnings beats provide some optimism. Key risks include execution of the business pivot and path to profitability. Wall Street shows cautious optimism with majority buy ratings despite fundamental headwinds.
VNM trades at $17.83, up 1.08% today, with a bullish overall technical signal from indicators. The stock shows mixed technical signals with bearish moving averages but bullish ADX readings, while support and resistance cluster tightly around $17-$18. Recent news highlights Vietnam's economic challenges, including power grid strain and foreign capital outflows from Asian equities, potentially impacting the ETF's holdings.
The outlook is cautious due to Vietnam's macroeconomic headwinds and ETF underperformance, though potential exists from FTSE Russell's EM reclassification. Key risks include regional economic volatility and sector-specific pressures, while institutional sentiment remains watchful amid these developments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About VanEck Vietnam ETF
VNM is the first and largest U.S.-listed ETF providing targeted exposure to the Vietnamese equity market. It tracks the MarketVector™ Vietnam Local Index, which includes publicly traded companies that are locally incorporated in Vietnam. It serves as a liquid, transparent vehicle for investors looking to participate in Vietnam's transition into a global manufacturing hub and its long-term potential for emerging market reclassification.
Read more on VNM →
